Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Vascular pool of releasable soluble VEGF receptor-1 (sFLT1) in women with previous preeclampsia and uncomplicated pregnancy.

Weissgerber TL, Rajakumar A, Myerski AC, Edmunds LR, Powers RW, Roberts JM, Gandley RE, Hubel CA.

J Clin Endocrinol Metab. 2014 Mar;99(3):978-87. doi: 10.1210/jc.2013-3277. Epub 2013 Dec 11.

2.

Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.

Wikström AK, Larsson A, Eriksson UJ, Nash P, Nordén-Lindeberg S, Olovsson M.

Obstet Gynecol. 2007 Jun;109(6):1368-74.

PMID:
17540809
3.

Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women.

Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA.

Am J Obstet Gynecol. 2006 Apr;194(4):1034-41.

PMID:
16580293
4.

Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia.

Wikström AK, Larsson A, Eriksson UJ, Nash P, Olovsson M.

Acta Obstet Gynecol Scand. 2008;87(2):146-53. doi: 10.1080/00016340701819262.

PMID:
18231881
5.

Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.

Powers RW, Roberts JM, Cooper KM, Gallaher MJ, Frank MP, Harger GF, Ness RB.

Am J Obstet Gynecol. 2005 Jul;193(1):185-91.

PMID:
16021077
6.

Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.

Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR.

Eur J Obstet Gynecol Reprod Biol. 2005 Sep 1;122(1):33-9.

PMID:
15935542
7.

Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1.

Bdolah Y, Elchalal U, Natanson-Yaron S, Yechiam H, Bdolah-Abram T, Greenfield C, Goldman-Wohl D, Milwidsky A, Rana S, Karumanchi SA, Yagel S, Hochner-Celnikier D.

Hypertens Pregnancy. 2014 May;33(2):250-9. doi: 10.3109/10641955.2013.858745. Epub 2013 Dec 4.

PMID:
24304210
8.

A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.

Sela S, Itin A, Natanson-Yaron S, Greenfield C, Goldman-Wohl D, Yagel S, Keshet E.

Circ Res. 2008 Jun 20;102(12):1566-74. doi: 10.1161/CIRCRESAHA.108.171504. Epub 2008 May 30.

9.

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA.

J Clin Invest. 2003 Mar;111(5):649-58.

10.

Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period.

Petrozella L, Mahendroo M, Timmons B, Roberts S, McIntire D, Alexander JM.

Am J Obstet Gynecol. 2012 Aug;207(2):140.e20-6. doi: 10.1016/j.ajog.2012.06.011. Epub 2012 Jun 11.

11.

[THE ROLE OF ANGIOGENIC FACTORS IN THE DIAGNOSTICS OF PREGNANCY COMPLICATED WITH PREECLAMPSIA].

Tagiyeva I, Aliyeva S, Bagirova S, Shamsadinskaya N, Agaeva K.

Georgian Med News. 2017 Jul-Aug;(268-269):35-38. Russian.

PMID:
28820409
12.

Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.

Wathén KA, Tuutti E, Stenman UH, Alfthan H, Halmesmäki E, Finne P, Ylikorkala O, Vuorela P.

J Clin Endocrinol Metab. 2006 Jan;91(1):180-4. Epub 2005 Nov 1.

PMID:
16263826
13.

A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy.

Palm M, Basu S, Larsson A, Wernroth L, Åkerud H, Axelsson O.

Acta Obstet Gynecol Scand. 2011 Nov;90(11):1244-51. doi: 10.1111/j.1600-0412.2011.01186.x. Epub 2011 Sep 6.

PMID:
21568945
14.

Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.

Rajakumar A, Michael HM, Rajakumar PA, Shibata E, Hubel CA, Karumanchi SA, Thadhani R, Wolf M, Harger G, Markovic N.

Placenta. 2005 Aug;26(7):563-73.

PMID:
15993706
15.

Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia.

Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O, Taketani Y.

J Clin Endocrinol Metab. 2003 May;88(5):2348-51.

PMID:
12727995
16.

Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia.

Stepan H, Faber R, Wessel N, Wallukat G, Schultheiss HP, Walther T.

J Clin Endocrinol Metab. 2006 Jun;91(6):2424-7. Epub 2006 Mar 28.

PMID:
16569734
17.

Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.

Adekola H, Romero R, Chaemsaithong P, Korzeniewski SJ, Dong Z, Yeo L, Hassan SS, Chaiworapongsa T.

J Matern Fetal Neonatal Med. 2015;28(14):1621-32. doi: 10.3109/14767058.2014.964676. Epub 2014 Oct 28.

18.

Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications.

Fan X, Rai A, Kambham N, Sung JF, Singh N, Petitt M, Dhal S, Agrawal R, Sutton RE, Druzin ML, Gambhir SS, Ambati BK, Cross JC, Nayak NR.

J Clin Invest. 2014 Nov;124(11):4941-52. doi: 10.1172/JCI76864. Epub 2014 Oct 20.

19.

Angiogenesis in gestational vascular complications.

Yagel S.

Thromb Res. 2011 Feb;127 Suppl 3:S64-6. doi: 10.1016/S0049-3848(11)70018-4.

PMID:
21262445
20.

Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole.

Koga K, Osuga Y, Tajima T, Hirota Y, Igarashi T, Fujii T, Yano T, Taketani Y.

Fertil Steril. 2010 Jun;94(1):305-8. doi: 10.1016/j.fertnstert.2009.02.015. Epub 2009 Mar 9.

PMID:
19269632

Supplemental Content

Support Center